Figure 9. Effect of the risk score and immune checkpoint gene expression on patient survival. (A) Correlation between the risk score and PD-1 gene expression. (B) Expression distribution of PD-1 gene in the high- and low-risk groups stratified by risk score. (C) Correlation between the risk score and CTLA4 gene expression. (D) Expression distribution of CTLA4 gene in the high- and low-risk groups stratified by risk score. (E) Kaplan–Meier survival curve of four groups stratified by the risk score and PD-1 expression. (F) Kaplan–Meier survival curve of four groups stratified by the risk score and CTLA4 expression.